Search

everythinglearnresearchcommunity

for

Search:↓

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

A parasite molecule can speed up skin healing and reduce scarring.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

3D spheroid culture makes stem cells better at reducing inflammation.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Betamethasone activates and increases the growth of certain skin cells from hair follicles.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

Immunotherapy can help treat severe alopecia areata.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Blocking IL-8 can reduce skin rashes from cancer treatment.